Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Accenture
Julphar
McKesson
UBS
Express Scripts
Merck
QuintilesIMS
AstraZeneca

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074260

« Back to Dashboard

NDA 074260 describes CARBIDOPA AND LEVODOPA, which is a drug marketed by Accord Hlthcare, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Sun Pharma Global, Actavis Elizabeth, Ani Pharms Inc, Apotex Inc, Mayne Pharma, SCS, and Watson Labs, and is included in twenty-one NDAs. It is available from twenty-six suppliers. Additional details are available on the CARBIDOPA AND LEVODOPA profile page.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 074260
Tradename:CARBIDOPA AND LEVODOPA
Applicant:Actavis Elizabeth
Ingredient:carbidopa; levodopa
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074260
Ingredient-typeAmino Acids, Aromatic
Suppliers and Packaging for NDA: 074260
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074260 ANDA Actavis Pharma, Inc. 0228-2538 N 0228-2538-10
CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074260 ANDA Actavis Pharma, Inc. 0228-2538 N 0228-2538-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG;100MG
Approval Date:Sep 3, 1993TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;100MG
Approval Date:Sep 3, 1993TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;250MG
Approval Date:Sep 3, 1993TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Cerilliant
Argus Health
Healthtrust
McKesson
Julphar
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.